Randomized Trial of Tofacitinib in Active Ulcerative Colitis: Analysis of Efficacy Based on Patient-Reported Outcomes

BMC Gastroenterology - United Kingdom
doi 10.1186/s12876-015-0239-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS (Review)

Koloproktologia
2018English

Exam 2: Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-Analysis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2018English

Pmu116 - Patient-Reported Outcomes in a Pilot Randomized Trial of Genome Sequencing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Ginger in Patients With Active Ulcerative Colitis: A Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2020English

AB0794 Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis: Results From Two Phase 3 Studies

2017English

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2019English

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

Gastroenterology
HepatologyGastroenterology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy